CareDx Inc CDNA

US Biotechnology

$43.71 ▲ +14.72% (+$5.61)

🎯 52W High ⬆️ Above Yest. High 🎢 High Beta

Open $42.49

Prev Close $38.10

Day Range $40.67 – $45.00

52W Range $11.26 – $45.00

Market Cap $2.26B

Beta 2.45

EPS (TTM) $-0.15

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2014-07-17
Shares Out.	51,660,000
Website	caredx.com/ ↗
Phone	14152872300
Employees	765
Revenue	$117.7M
Gross Profit	$84.1M
Net Income	$2.8M
Free Cash Flow	$64.8M
Total Assets	$411.1M
Total Liabilities	$97.5M
Equity	$313.5M

About CareDx Inc

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

CareDx Inc is a publicly traded company under the ticker symbol CDNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.